Motus GI Holdings, Inc. Innovation Day: The Pure-Vu EVS System
|DATE:||January 25, 2022|
|TIME:||12:00 AM EST|
About The Event
This event will focus on the Company’s initiative to drive product innovation, which includes the recent public introduction of the Pure-Vu EVS System (awaiting FDA clearance) as the third generation Pure-Vu System, ongoing market evaluation of the Pure-Vu System Upper GI sleeve (FDA cleared), as well as, a review of several ongoing and planned clinical studies. These innovations are building upon the Company’s commercial launch of the Pure-Vu System in the U.S., which has successfully established an installed base across several key influencer hospitals in the GI market.
In addition to presentations by Motus GI’s leadership, the event will feature insights from Key Opinion Leader (KOL), Seth A. Gross, MD (Clinical Chief of the Division of Gastroenterology and Hepatology at NYU Langone Health and Professor, Department of Medicine at NYU Langone Health) who will discuss his experiences with the Pure-Vu Platform and it’s applicability in daily practice.
The Pure-Vu EVS is the third generation of the Company’s System that will offer continued advancement over the current Platform, including enhanced ease-of-use, further cleaning capacity, upper and lower GI capabilities, and a smaller workstation footprint. The Pure-Vu EVS System is currently being reviewed by the FDA under 510(k) clearance process.
A question and answer session will follow the formal presentations.